InvestorsObserver
×
News Home

LivaNova PLC (LIVN) Stock: What Does the Chart Say Monday?

Monday, April 12, 2021 02:25 PM | InvestorsObserver Analysts

Mentioned in this article

LivaNova PLC (LIVN) Stock: What Does the Chart Say Monday?

Overall market sentiment has been high on LivaNova PLC (LIVN) stock lately. LIVN receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
LivaNova PLC has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on LIVN!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.

Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With LIVN Stock Today?

LivaNova PLC (LIVN) stock is up 0.36% while the S&P 500 has fallen -0.13% as of 2:14 PM on Monday, Apr 12. LIVN has gained $0.29 from the previous closing price of $80.00 on volume of 343,121 shares. Over the past year the S&P 500 has risen 49.32% while LIVN has gained 63.19%. LIVN lost -$7.07 per share in the over the last 12 months.

To see the top 5 stocks in the Medical Devices industry click here.

More About LivaNova PLC

U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.

Click Here to get the full Stock Score Report on LivaNova PLC (LIVN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App